Skip to main content
Log in

Elevation of alkaline phosphatase and long-term drug therapy for cystic fibrosis

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

The authors confirm that the data supporting the findings of this study are available within the article or its supplementary materials.

References

  1. Kent JR, Almond MK, Dhillon S (2001) Azithromycin: an assessment of its pharmacokinetics and therapeutic potential in CAPD. Perit Dial Int 21(4):372–7

  2. Sugie M, Asakura E, Zhao YL, Torita S, Nadai M, Baba K, Kitaichi K, Takagi K, Takagi K, Hasegawa T (2004) Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin. Antimicrob Agents Chemother 48(3):809–814

    Article  CAS  Google Scholar 

  3. Nguyen TD, Markova S, Liu W, Gow JM, Baldwin RM, Habashian M, Relling MV, Ratain MJ, Kroetz DL (2013) Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression. Pharmacogenomics J 13(5):396–402

    Article  CAS  Google Scholar 

  4. Robertson SM, Luo X, Dubey N, Li C, Chavan AB, Gilmartin GS, Higgins M, Mahnke L (2015) Clinical drug-drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P-glycoprotein. J Clin Pharmacol 55(1):56–62

    Article  CAS  Google Scholar 

  5. Howsare MM, El-Kersh K (2017) Isolated extreme elevation of alkaline phosphatase associated with lumacaftor/ivacaftor therapy: first report. Am J Respir Crit Care Med 195:A1509

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philippe Hantson.

Ethics declarations

Ethical statement

The patient’s relatives gave written informed consent for publication of the case report.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Delmez, Q., Haufroid, V., Gohy, S. et al. Elevation of alkaline phosphatase and long-term drug therapy for cystic fibrosis. Eur J Clin Pharmacol 78, 699–701 (2022). https://doi.org/10.1007/s00228-021-03272-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-021-03272-0

Keywords

Navigation